跳至主要内容
临床试验/CTRI/2022/09/046077
CTRI/2022/09/046077尚未招募2 期

Clinical evaluation of the efficacy of ayurvedic compound drug (Ashwagandhadi capsule) in Hypertension with special reference to Rakta gata vata

Department of kayachikitsa Faculty of ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Patients willing to participate in study
  • 2 Either sex of age between 18 t0 60 years
  • 3 Stage I HTN (Systolic blood pressure 140-159mmHg and Diastolic blood pressure 90-99mmHg)
  • 4 Isolated systolic HT

排除标准

  • 1 Patients not willing to participate in the study
  • 2 Patients of either sex below 18 years & above 60 years will be excluded from the study
  • 3 Patients of Stage II Hypertension (Systolic Blood Pressure >160mmHg and Diastolic Blood Pressure >100mmHg)
  • 4 Patients suffering from serious comorbidities like renal failure, coronary artery disease, Type 2 Diabetes Mellitus, cervical spondylosis, taking medications/drugs (oral contraceptives, steroids, chronic use of NSAIDs etc.)
  • 5 Alcoholics and/or drug abusers
  • 6 History of hypersensitivity to the trial drug or any of its ingredients
  • 7 Pregnant/ lactating woman

研究者

发起方
Department of kayachikitsa Faculty of ayurveda

相似试验